| A generalized HIV vaccine design strategy for priming of broadly neutralizing antibody responses JM Steichen, YC Lin, C Havenar-Daughton, S Pecetta, G Ozorowski, ... Science 366 (6470), eaax4380, 2019 | 215 | 2019 |
| Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022 A Nandi, S Pecetta, DE Bloom EClinicalMedicine 57, 2023 | 148 | 2023 |
| Vaccinology in the post− COVID-19 era R Rappuoli, E De Gregorio, G Del Giudice, S Phogat, S Pecetta, M Pizza, ... Proceedings of the National Academy of Sciences 118 (3), e2020368118, 2021 | 96 | 2021 |
| Molecular and Immunological Characterization of Staphylococcus aureus in Pediatric Atopic Dermatitis: Implications for Prophylaxis and Clinical Management C Pascolini, JL Sinagra, S Pecetta, V Bordignon, A De Santis, L Cilli, ... Journal of Immunology Research 2011 (1), 718708, 2011 | 70 | 2011 |
| Transforming vaccine development S Black, DE Bloom, DC Kaslow, S Pecetta, R Rappuoli Seminars in immunology 50, 101413, 2020 | 62 | 2020 |
| Quantum leap of monoclonal antibody (mAb) discovery and development in the COVID-19 era S Pecetta, O Finco, A Seubert Seminars in immunology 50, 101427, 2020 | 61 | 2020 |
| LytM proteins play a crucial role in cell separation, outer membrane composition, and pathogenesis in nontypeable Haemophilus influenzae G Ercoli, C Tani, A Pezzicoli, I Vacca, M Martinelli, S Pecetta, R Petracca, ... MBio 6 (2), 10.1128/mbio. 02575-14, 2015 | 46 | 2015 |
| Carrier priming with CRM197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: Biophysical and immunochemical interpretation S Pecetta, PL Surdo, M Tontini, D Proietti, C Zambonelli, MJ Bottomley, ... Vaccine 33 (2), 314-320, 2015 | 46 | 2015 |
| One‐step CRISPR/Cas9 method for the rapid generation of human antibody heavy chain knock‐in mice YC Lin, S Pecetta, JM Steichen, S Kratochvil, E Melzi, J Arnold, ... The EMBO journal 37 (18), e99243, 2018 | 39 | 2018 |
| Membrane-bound mRNA immunogens lower the threshold to activate HIV Env V2 apex-directed broadly neutralizing B cell precursors in humanized mice E Melzi, JR Willis, KM Ma, YC Lin, S Kratochvil, ZT Berndsen, EA Landais, ... Immunity 55 (11), 2168-2186. e6, 2022 | 35 | 2022 |
| Recent advances and future perspectives on carbohydrate-based cancer vaccines and therapeutics C Sorieul, F Papi, F Carboni, S Pecetta, S Phogat, R Adamo Pharmacology & Therapeutics 235, 108158, 2022 | 30 | 2022 |
| Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies I Sanjuan Nandin, C Fong, C Deantonio, JA Torreno-Pina, S Pecetta, ... Journal of Experimental Medicine 214 (8), 2471-2490, 2017 | 30 | 2017 |
| Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS) R Rappuoli, P Young, E Ron, S Pecetta, M Pizza One Health Outlook 5 (1), 5, 2023 | 27 | 2023 |
| Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 … S Pecetta, M Tontini, E Faenzi, R Cioncada, D Proietti, A Seubert, S Nuti, ... Vaccine 34 (20), 2334-2341, 2016 | 27 | 2016 |
| The trillion dollar vaccine gap S Pecetta, D Tortorice, FB Scorza, M Pizza, G Dougan, R Hatchett, ... Science Translational Medicine 14 (638), eabn4342, 2022 | 23 | 2022 |
| Vaccines 2020: the era of the digital vaccine is here M Pizza, S Pecetta, R Rappuoli Science Translational Medicine 13 (624), eabm3249, 2021 | 22 | 2021 |
| Investigating the immunodominance of carbohydrate antigens in a bivalent unimolecular glycoconjugate vaccine against serogroup A and C meningococcal disease R Adamo, A Nilo, C Harfouche, B Brogioni, S Pecetta, G Brogioni, ... Glycoconjugate journal 31, 637-647, 2014 | 21 | 2014 |
| mRNA, the beginning of a new influenza vaccine game S Pecetta, R Rappuoli Proceedings of the National Academy of Sciences 119 (50), e2217533119, 2022 | 18 | 2022 |
| The immune evasion roles of Staphylococcus aureus protein A and impact on vaccine development A Bear, T Locke, S Rowland-Jones, S Pecetta, F Bagnoli, TC Darton Frontiers in Cellular and Infection Microbiology 13, 1242702, 2023 | 17 | 2023 |
| Vaccines for a sustainable planet S Pecetta, A Nandi, C Weller, V Harris, H Fletcher, F Berlanda Scorza, ... Science Translational Medicine 15 (685), eadf1093, 2023 | 16 | 2023 |